Fas gene mutation in the progression of adult T cell leukemia - Wikidata - wikimedia - TriplyDB

Fas gene mutation in the progression of adult T cell leukemia

Fas gene mutation in the progression of adult T cell leukemia

http://www.wikidata.org/entity/Q40962746

about

P1343

Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study.Cellular stress responses: cell survival and cell death Soluble Fas (APO-1/CD95) isoform in adult T-cell leukemia.LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells.Human T-cell leukemia virus type I and adult T-cell leukemia.Cutaneous type of adult T cell leukemia/lymphoma: a new entity among cutaneous lymphomas.Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.Variegated RHOA mutations in adult T-cell leukemia/lymphoma.CD95-mediated cell signaling in cancer: mutations and post-translational modulations.Tumor evasion from T cell surveillance.Molecular hallmarks of adult T cell leukemia.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.Downregulation of proapoptotic Bim augments IL-2-independent T-cell transformation by human T-cell leukemia virus type-1 Tax.Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.CD95 ligand mediates T-cell receptor-induced apoptosis of a CD4+ CD8+ double positive thymic lymphoma.Identification of MMP-15 as an anti-apoptotic factor in cancer cells.Multiple gammac-receptor expression in adult T-cell leukemia.Relationships of diverse apoptotic death process patterns to mitochondrial membrane potential (Δψ(m)) evaluated by three-parameter flow cytometric analysis.Trifluoperazine regulation of calmodulin binding to Fas: a computational study.Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistochemical study.CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer.Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer.Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL.Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma.

P2860

Q54899965-E0692BB6-FB34-4D92-A371-AE7210445F13 Q95962168-0985BF99-28AA-46D7-A17E-3178A139DB2E

P1343

Q24802464-B3634F26-7261-4B2C-8B27-00D3048AEBF9 Q24805664-8CD7A90D-B0F3-4A96-A82E-45A01A6AA722 Q24811356-D1335284-594D-4E88-A67B-A3919EFB17AD Q33558240-EA4E843E-1A1C-46FC-BEB0-A69008EAFAE4 Q33674213-4BE31008-0DD0-4184-B7D5-50931D97E54E Q34244551-0D9FA83D-B0D2-49AB-91AE-353CF4D2E408 Q34952741-C7EEB711-48F1-48A7-8697-3B95ED34B0E9 Q35051987-9EB9B9FD-0E6D-4E6B-B4F7-192610543500 Q35196605-14E38B62-04DD-4056-AE63-A2F1772F11A9 Q35567913-FFEE6FAC-B9C2-4257-9BEA-033F99D39CBA Q35748214-FE07AAB1-A33E-4929-B023-305C38801B34 Q36771229-3492BC48-452A-4F83-B7C4-167DBA09FD05 Q37008175-6AAAA314-2E86-4086-AB90-826CBEDB392A Q37079191-086C269B-7C5D-46C2-8104-27C1444DE545 Q37623824-41778641-DD01-4D6F-9CF9-3A663BEF89B8 Q37951369-796B87F4-4CB9-46AD-B77A-621D94BED762 Q37970674-5B8C1876-AA14-4125-B128-F76AAFE9F6CF Q38051633-B46C7436-D0B0-48BA-9501-673DABE7D1A2 Q38170150-C3E1D4D2-8347-4479-8E76-A9E3DF717376 Q38530097-011DD969-12E8-499D-9046-528AFC46FB63 Q38770098-07D3D70D-C69F-4629-8994-0C8424C9CB06 Q38961040-F29A6C11-F3B3-479A-80FF-378A52B87381 Q39539189-D66EC098-711B-422B-8FA1-BF5B1F99192A Q39773550-BBB9F357-2081-4A2B-8882-F03E10BDDAA8 Q40269059-898D312A-9143-4FF1-8692-41CE047E9BE7 Q40386669-C086BB21-DD72-4A78-AD6C-0B63F65B6421 Q40704768-AE682087-9EE9-40EC-A5FD-57B19F7121BD Q41762192-1C9221BD-F576-4A55-9CBE-77BB8056A2A5 Q41850711-1043A001-1594-41A5-9962-61E64B54AAA9 Q42096876-4E2B8CD0-A078-48BD-B9AE-B142122CEB56 Q42805759-FA18BDE7-5E85-431B-829B-D6EEF76BF997 Q43687388-AD522A32-0F03-419A-9F38-C6A058D0A81B Q53663811-10EFDC3C-9AB2-4176-B2C3-201A2AD2A1D3 Q53939721-87ED06CF-CD58-411E-9564-B28578A9E054 Q53969544-F3416586-20DA-4A87-8A93-0E968197D789 Q54021470-CC96F44B-0F21-45DB-895F-7B72173A9EAE Q55239224-5771867A-52F6-42A6-A364-A0F41550BDE8 Q55239517-C21DFDB5-7083-4D5B-A56D-6FF3207C4804 Q55239618-DBC0262B-35B3-4B26-8E8A-1C9B13424562

P2860

Fas gene mutation in the progression of adult T cell leukemia

http://www.wikidata.org/entity/Q40962746

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Fas gene mutation in the progression of adult T cell leukemia

@en

type

label

Fas gene mutation in the progression of adult T cell leukemia

@en

prefLabel

Fas gene mutation in the progression of adult T cell leukemia

@en

P1433

Q40962746-ABD02FEA-D5D8-42F4-A8D9-E2BE5E8160F7

P1476

Q40962746-31DD4001-F4C9-4C05-B4A1-31A0DDD705D1

P2093

Q40962746-04986268-A521-43C4-A258-7DE6D64C09FA

Q40962746-11FD9F81-8322-4A4B-9942-EF9A69454180

Q40962746-21BD5BBB-4FBB-44A5-9F69-41FB78A0B7CD

Q40962746-4D83A87D-9085-453B-A467-950183E87095

Q40962746-58AA3CC1-4A75-475D-8CDD-BF287C09A249

Q40962746-6A6AC0C1-2223-4CBC-8277-5F2DC94BBB39

Q40962746-871A2E58-91B9-4609-AEB7-89FC978AD790

Q40962746-ADB0A8EE-D876-4760-8D7E-C9227C605FCE

Q40962746-DC179241-AE57-4E5B-AFD3-8F2260791EB8

Q40962746-E4DF37BD-49D6-4CBA-A9C6-32AE2F50779F

P2860

Q40962746-052F95AD-6BDB-4296-9E6F-410CB8F9C6CE

Q40962746-074CBBC4-BE5E-4F28-9E9F-6AE5A0FD01C7

Q40962746-09BA70CE-72C9-4115-85C6-3D65299FBE5E

Q40962746-18E020E9-7D8C-48A1-9FF2-12D9C2804D23

Q40962746-1AE2EE41-3111-4A9B-805E-778D00421E53

Q40962746-244D4514-FADD-4779-A9F7-85F2750CDC74

Q40962746-255F4874-6922-4288-AA23-2F9B7E0899B5

Q40962746-2A7FD89A-1861-4AC2-AF61-8E2599675480

Q40962746-2FDC9F98-60FD-40FE-ACE5-49540733420D

Q40962746-320EA582-1754-497E-9175-3DD63DD30F88

P304

Q40962746-C6C54BD0-FD2B-40F7-ACB8-9FC578F346AC

P31

Q40962746-58ADB63F-6E26-44BE-A342-4997FEC0C046

P356

Q40962746-D8A399E6-52C7-430B-AAE5-ED9A91DF4AB8

P407

Q40962746-B4CFBC99-7B64-4111-907F-E7DD6AEF4ED5

P433

Q40962746-F47525DF-A824-4D3C-A2F6-B254FF39A60A

P478

Q40962746-3BDF8B30-FCCB-49BB-92AA-97BB774F916D

P577

Q40962746-BE6041D2-30BE-4945-A899-3A2C4FA8A64E

P5875

Q40962746-410C176D-40DD-49D7-9318-2139D1BACA7D

P698

Q40962746-21D5F455-4668-4B6E-9C2E-D4B108FC3E94

P921

Q40962746-23D0A75E-7BFD-4C98-B0F0-89797A6B17AF

P932

Q40962746-4B5CF795-BA51-4742-8E1D-5F278973D3F0

P356

P1433

Journal of Experimental Medicine

P1476

Fas gene mutation in the progression of adult T cell leukemia

@en

P2093

Atogami S

http://www.w3.org/2001/XMLSchema#string

Joh T

http://www.w3.org/2001/XMLSchema#string

Kamihira S

http://www.w3.org/2001/XMLSchema#string

Maeda T

http://www.w3.org/2001/XMLSchema#string

Moriuchi R

http://www.w3.org/2001/XMLSchema#string

Sugahara K

http://www.w3.org/2001/XMLSchema#string

Tomonaga M

http://www.w3.org/2001/XMLSchema#string

Tsukasaki K

http://www.w3.org/2001/XMLSchema#string

Tsuruda K

http://www.w3.org/2001/XMLSchema#string

Yamada Y

http://www.w3.org/2001/XMLSchema#string

P2860

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos

Apoptosis by death factor

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

P304

1063-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.189.7.1063

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13107060

http://www.w3.org/2001/XMLSchema#string

P698

10190897

http://www.w3.org/2001/XMLSchema#string

P921

P932

2193006

http://www.w3.org/2001/XMLSchema#string